← 返回首页
美国 · 通讯社与实时数据 · PR Newswire

SAS and Posit partner for governed AI in life sciences

来源:PR Newswire · 美国 36 分钟前
SAS and Posit have partnered to give life science organizations more flexibility to use SAS and open source technologies.
SAS and Posit have partnered to give life science organizations more flexibility to use SAS and open source technologies. · PR Newswire

详细摘要

Collaboration will bring SAS and open source technologies together to support clinical development and regulatory requirements CARY, N.C., Nov. 16, 2026 /PRNewswire/ -- SAS, a…

Collaboration will bring SAS and open source technologies together to support clinical development and regulatory requirements

CARY, N.C., Nov. 16, 2026 /PRNewswire/ -- SAS, a global leader in data and AI, and Posit PBC (formerly RStudio) have partnered to give life science organizations more flexibility to use SAS and open source technologies, with an initial focus on clinical development. The partnership will integrate SAS® Viya® and SAS® Clinical Acceleration with Posit technologies including Posit Workbench, Positron, Posit Connect and Posit Package Manager. With SAS' analytics and governance capabilities combined with Posit's open source offerings, they will provide customers with more options for working seamlessly with SAS and R while supporting regulatory requirements.

SAS Clinical Acceleration is built on SAS Viya, SAS' data and AI platform. It combines a secure clinical data repository, statistical computing environment and AI-assisted clinical data transformations to prepare clinical research for regulatory submission. Posit's offerings will extend those capabilities, giving users a secure way to incorporate open source technology in a managed enterprise environment.

"Life sciences organizations can now bring together the flexibility of open source with the rigor required for regulated clinical research," said Mark Lambrecht, Global Head, Health Care and Life Sciences Solutions at SAS. "Our partnership with Posit will give customers more freedom without compromising the need for transparency and governance."

"Clinical teams have asked us for a way to use R and Python without giving up the controls they rely on in SAS," said Eric Pite, Senior Vice President of Product and Strategy at Posit. "Today, a programmer can write SAS and R code in Positron, and SAS Viya runs the SAS code under that programmer's own permissions. We are working with our joint customers to decide which clinical workflows to support next."

The collaboration means customers can work in…

"Usin…

文章开头,摘自PR Newswire。如需阅读全文,请前往媒体网站。

在 PR Newswire 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.prnewswire.com)

推荐阅读